Placental growth factor (PlGF), which is significantly associated with CD90 expression, was significantly correlated, and high levels of both PlGF and CD90 were associated with tumor angiogenic markers (CD31, CD34, and CD105 (Liu et al. 2020). This evidence concerns the gene THY1 and neoplasm.